Concepedia

Publication | Open Access

CD44v6 chimeric antigen receptor T cell specificity towards AML with FLT3 or DNMT3A mutations

DOIFull Paper Access

40

Citations

29

References

2022

Year

Ling Tang, Hongming Huang, Yutong Tang, Qing Li, Jue Wang, Dengju Li, Zhaodong Zhong, Ping Zou, Yong You, Yang Cao,
Clinical and Translational Medicine

Abstract

Collectively, CD44v6 is a promising target of CAR-T for AML patients with FLT3 or DNMT3A mutations.

References

YearCitations

Page 1